Defense Rests In Stem Cell Trial; Briefs Due June 8, Trial Will Resume July 9

(May 17, 2021, 2:30 PM EDT) -- RIVERSIDE, Calif. — Defendants on May 13 rested in a federal civil bench trial in which the United States alleges that a purported stem cell medical treatment clinic violated the Food, Drug and Cosmetic Act (FDCA) by processing patients’ stem cells to treat a variety of health conditions....

Related Sections